Cholesterol atheroembolism and combined treatment with steroids and iloprost.

Cholesterol atheroembolism (CAE) is a systemic disorder whose incidence has increased in recent decades and that presents high morbidity and mortality. Although several therapeutic alternatives have been reported, there is no consensus about the best treatment for this disease. In this paper we report the case of a patient with CAE with skin, bowel and kidney involvement who presented a good response to combined therapy with steroids and prostaglandin analogues. Although there are no conclusive studies, we recommend this therapeutic alternative in the management of CAE with organic failure.
AuthorsÁngel M Sevillano-Prieto, Eduardo Hernández-Martínez, Jara Caro-Espada, María Molina-Gómez, Eduardo Gutiérrez-Martínez, Enrique Morales-Ruiz, Ester González-Monte, Manuel Praga-Terente
JournalNefrología : publicación oficial de la Sociedad Española Nefrologia (Nefrologia) Vol. 32 Issue 6 Pg. 824-8 ( 2012) ISSN: 1989-2284 [Electronic] Spain
PMID23169366 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Steroids
  • Iloprost
  • Aged
  • Drug Therapy, Combination
  • Embolism, Cholesterol (drug therapy)
  • Female
  • Humans
  • Iloprost (therapeutic use)
  • Steroids (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: